Sudan Pharmaceuticals and Healthcare Report Q1 2014:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Join Delanceyplace Sign up to receive a free quote from a non fiction book every weekday. From our sponsors

Sudan Pharmaceuticals and Healthcare Report Q1 2014 Nov 20th 2013, 00:00, by vyankatesh BMI View: Disparity in the official and black market currency exchange rates, corruption and continual political tensions between Sudan and South Sudan will remain as downside risks to investments into the pharmaceutical sector. Consequently, we do not expect the market to be of particular interest to foreign pharmaceutical players. Headline Expenditure Projections ? Pharmaceuticals: SDG1.92bn (US$540mn) in 2012 to SDG2.37bn (US$500mn) in 2013; +23.6% in local currency terms with a contraction of -7.1% in US dollar terms. Forecast broadly in line with Q413, growth contractions in US dollar terms due to currency fluctuations. Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=131671. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/sudan-pharmaceuticals-and-healthcare-report-q1-2014-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions